CDH1 and ovarian carcinoma: It has also been demonstrated that histone deacetylase inhibitors exhibit anti-cancer activity and induces apoptosis in ovarian cancer cells via up-regulation of E-cadherin expression and accumulation of acetylated histones H3 and H4.